Health
Preventative nasal spray shown to reduce viral replication by up to 96% in COVID-19 challenge study – PRNewswire
New preventative nasal spray treatment that could protect people from COVID-19 infection and prevent transmission announced Novel therapy developed by…
- New preventative nasal spray treatment that could protect people from COVID-19 infection and prevent transmission announced
- Novel therapy developed by Australian biotech company, Ena Respiratory, shown to significantly reduce COVID-19 virus levels in the nose and throat, in a gold-standard animal study
- Reduced COVID-19 replication by up to 96%, study performed by Public Health England (PHE) scientists
- Mode of action complementary to COVID-19 vaccines, with easy n…
Continue Reading
-
General12 hours agoVictorian school teacher charged with soliciting child abuse material
-
Business21 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business23 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
Business20 hours agoHere’s what analysts expect for the BHP share price in the coming year